Company
Company

Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.

Check also Companies to Follow in 2022 and CMN Markets for the latest stock and market trends.

Always stay updated with the free CMN Newsletter.

EMERZENE

Main Focus
Gene Editing, Pain Relief, Non-addictive Opiates

Company Stage
Pre-clinical

Disease Focus
Cancer, Pain management

Technology | Tool
CRISPR, ZFN'S

Funding Stage
SEED

Location
DUBLIN, CALIFORNIA

Website
https://www.emerzenetx.com

Pipeline
https://www.emerzenetx.com

Partners
MERCK, NIST

Tags

HashtagEMERZENE

Company: EMERZENE
Jobs, banner ads, webinars, sponsored content...
close
Search CRISPR Medicine